Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia-Reference-Cited by-同舟云学术

Low ADAMTS‐13 predicts adverse outcomes in hospitalized patients with suspected heparin‐induced thrombocytopenia

Published:2021-08 Issue:6 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Chan Meng¹,Zhao Xinyang²,Zheng X. Long¹^ORCID

Affiliation:

1. Departments of Pathology and Laboratory Medicine The University of Kansas Medical Center Kansas City KSUSA

2. Departments of Biochemistry and Molecular Genetics The University of Alabama at Birmingham Birmingham AL USA

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12581

Reference67 articles.

1. Heparin-induced thrombocytopenia: a historical perspective

2. Management of heparin-induced thrombocytopenia

3. Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

4. Heparin‐associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4‐heparin complex as the major antigen;Greinacher A;Thromb Haemost,1994

5. Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4–heparin antibodies to platelets and the resultant platelet activation

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Highs and Lows of ADAMTS13 Activity;Journal of Clinical Medicine;2024-08-30

2. Clinical Utility of Recently Food and Drug Administration-Approved IntelliSep Test (Sepsis Biomarker) for Early Diagnosis of Sepsis: Comparison with Other Biomarkers;Journal of Clinical Medicine;2024-08-16

3. Dynamic Assessment of Plasma von Willebrand Factor and ADAMTS13 Predicts Mortality in Hospitalized Patients with SARS-CoV-2 Infection;Journal of Clinical Medicine;2023-11-19

4. Immune thrombotic thrombocytopenic purpura: pathogenesis and novel therapies: a narrative review;Annals of Blood;2023-09

5. New perspectives on the induction and acceleration of immune-associated thrombosis by PF4 and VWF;Frontiers in Immunology;2023-02-28